Semaglutide peptide is a synthetic glucagon-like peptide-1 (GLP-1) analog with significant research potential in metabolic studies. This 31-amino acid peptide shares 94% homology with native human GLP-1 and has been modified with a C-18 fatty diacid chain at position 26 to prolong its action.
Our pharmaceutical grade semaglutide peptide is produced under strict GMP conditions with purity exceeding 99.9%. The compound shows excellent stability with proper storage conditions and maintains consistent batch-to-batch quality for research applications.
The semaglutide peptide is supplied as a lyophilized powder in various research quantities from 5mg to 30mg vials. Each batch undergoes rigorous HPLC and MS analysis to verify identity, purity, and molecular weight (4113.57754).
Key features of our semaglutide peptide include:
This product is intended for research purposes only and not for human consumption. Proper laboratory handling procedures should be followed when working with semaglutide peptide materials.